mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.055 |
0.1 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.054 |
0.1 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.055 |
0.1 |
mRNA |
FTI-277 |
GDSC1000 |
pan-cancer |
AAC |
0.053 |
0.1 |
mRNA |
KW-2449 |
CTRPv2 |
pan-cancer |
AAC |
-0.048 |
0.1 |
mRNA |
GDC-0449 |
GDSC1000 |
pan-cancer |
AAC |
-0.056 |
0.1 |
mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.08 |
0.1 |
mRNA |
PD-0325901 |
CCLE |
pan-cancer |
AAC |
0.067 |
0.1 |
mRNA |
GSK690693 |
GDSC1000 |
pan-cancer |
AAC |
-0.049 |
0.1 |
mRNA |
bafilomycin A1 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
0.1 |